Which DoD contractors need CMMC, who assesses each level, how long a status stays current, and what the rules say about mergers and acquisitions.
How ASC 350-40, ASC 985-20 and FASB’s 2025 update decide whether SaaS development costs are capitalized or expensed, and why novel AI features matter.
NIST’s voluntary AI risk framework, an FTC case on accuracy claims and California’s automated-decision rules: what an ML platform should document.
When an AI company is sold, CCPA rules can govern how its personal data passes to the buyer, and FTC orders show models can be lost with the data.
US copyright protects only human-authored work, and only people can be named as US patent inventors: what a generative AI startup can own and register.
How section 174’s five-year amortization, the 2025 section 174A deduction and the research credit change an AI company’s taxable income and tax.
What ONC certification requires of an EHR developer, how information blocking rules treat data export fees, and when a certification ban applies.
Which AI diagnostic software FDA treats as a device, how a PCCP covers model updates, and what happens to a 510(k), PMA or CLIA certificate in a sale.
Client relationships in an RCM company’s price, the HIPAA business associate agreement behind each one, and Medicare’s fee conditions for billing agents.
Who may own a telehealth medical practice in California, why its Medicare billing number cannot be sold, and how a valuer reads its earnings.